
    
      The efficacy and safety of E0671 in combination with Rabeprazole Sodium (i.e., 10 mg/day of
      rabeprazole sodium and 150 mg/day of E0671) will be investigated in patients with gastric
      ulcer in a multicenter, randomized, double-blind, parallel-group comparative study using a
      placebo control group (10 mg/day of rabeprazole sodium and placebo for E0671).
    
  